在非手术性牙周治疗 (NSPT) 和高血压之间的关联中,系统性炎症的调解作用:测试一个假设
Wei He1, Chao Liu2,3, Yingying Xu1
1Jiangxi Provincial Key Laboratory of Oral Diseases, Department of Stomatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Oral diseases
|March 7, 2026
概括
非手术性牙周治疗 (NSPT) 因果性地降低了患上新发高血压的风险. 然而,这种保护作用并非通过涉及全身炎症的途径进行介导.
科学领域:
- 心血管健康 心血管健康
- 牙周病学 牙周病学
- 炎症研究 炎症研究
背景情况:
- 牙周炎是一种影响牙的慢性炎症状况.
- 高血压是心血管疾病的主要危险因素.
- 牙周健康与诸如高血压之类的全身性疾病之间的联系是一个正在积极研究的领域.
研究的目的:
- 为了确定非手术性牙周治疗 (NSPT) 是否导致高血压新病例的减少.
- 调查系统性炎症是否在NSPT和高血压之间的关系中起到调解作用.
主要方法:
- 一项回顾性队列研究分析了2015-2021年期间患有牙周炎的患者.
- 患者被分为NSPT (治疗) 和没有NSPT (控制) 组.
- 在随访期间跟踪系统性炎症标志物和高血压的发展;采用因果调解分析.
主要成果:
- 非手术性牙周治疗 (NSPT) 在降低发生性高血压的风险方面表现出显著的因果关系.
- 该研究发现,高水平的全身炎症对NSPT与高血压相关性没有显著的调解效应.
- NSPT对高血压的保护作用是一致的,并且独立于炎症标志物.
结论:
- 非手术性牙周治疗 (NSPT) 与患高血压的风险较低有关.
- 系统性炎症似乎不是NSPT对高血压施加保护作用的机制.
- 需要进一步的研究来探索将牙周治疗与心血管结果联系起来的替代途径.
相关概念视频
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Disorders of the Autonomic Nervous System
1.8K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies
690
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension IV: Drug Therapy and Lifestyle Modifications
797
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
797
Psychoneuroimmunology: Cardiovascular Disease
633
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
633
Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540


